BioCentury Back to School 2025

33 Years of Insight. One Critical Issue for Biopharma’s Future.

BioCentury’s Back to School series has, every year since our founding, delivered deep, forward-looking analysis on the single most important issue shaping the biopharma industry. This year, we focus on how to reimagine FDA and the regulatory system that will define the pace and scope of innovation for decades to come.

In our 33rd annual Back to School package, BioCentury’s award-winning journalists and analysts dissect the forces shaping U.S. regulation of medicines, the structural changes needed to unleash innovation, and bold proposals for reform.

Why This Matters

• Critical Insight: FDA decisions set the pace for innovation. This package explores how to make the system work for patients, innovators, and investors.
• Expert Analysis: Perspectives from industry veterans, policy experts, and BioCentury’s editorial leaders.
• Actionable Intelligence:Use these insights to guide regulatory strategy, investment decisions, and policy engagement.

Fill out the form to start your free trial and access BioCentury's Back to School 2025 today.